Arthur J. Gallagher
AJG NYSE Insurance Brokers Financials FY2016βFY2025
Arthur J. Gallagher's revenue rose 20.7% to $13.9 billion in fiscal 2025. Its net margin was 10.7%, down from 12.7% a year earlier. Free cash flow was $1.8 billion, down 26.9%. It paid out $667 million in dividends and buybacks, 37% of free cash flow. The diluted share count rose 16.1%.
What Arthur J. Gallagher does
No business description yet.
- Legal name
- ARTHUR J. GALLAGHER & CO.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001628280-26-008662
0000354190
Revenue and margins
Arthur J. Gallagher had $13.9B of revenue in fiscal 2025, up 20.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 11.1% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $1.8B in fiscal 2025, 12.8% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Arthur J. Gallagher returned $667M to shareholders in fiscal 2025, 37% of free cash flow. The diluted share count rose 16.2%.
Value Arthur J. Gallagher yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$12.1B and divides by 256.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 44.5x Β· peers 21.6x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Arthur J. Gallagher can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $403M | $738M | $971M | $15.0B | $1.4B |
| Debt incl. finance leases | $268M | $327M | $694M | $223M | $13.5B |
| Net debt / EBITDA | β0.1x | β0.2x | β0.1x | β4.8x | 3.3x |
| Debt / equity | 0.0x | 0.0x | 0.1x | 0.0x | 0.6x |
| Interest coverage | 5.3x | 6.2x | 5.0x | 5.9x | 3.9x |
| Current ratio | 1.1x | 1.0x | 1.0x | 1.5x | 1.1x |
| Quick ratio | 1.1x | 1.0x | 1.0x | 1.5x | 1.1x |
| Total assets | $33.2B | $38.4B | $51.6B | $64.3B | $70.7B |
| Total liabilities | $24.8B | $29.2B | $40.8B | $44.1B | $47.3B |
| Shareholders' equity | $8.5B | $9.1B | $10.8B | $20.2B | $23.3B |
| Net debt (β = net cash) | β$135M | β$412M | β$277M | β$14.8B | $12.1B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$23.0M
6 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Richard C CaryController, CAO | Sold | 1,000 | $252.86 | $0.3M | Form 4 |
| Sep 2, 2026 | Scott R HudsonVice President | Sold | 12,000 | $264.13 | $3.2M | Form 4 |
| Aug 24, 2026 | Walter D. BayGeneral Counsel | Sold | 12,000 | $270.08 | $3.2M | Form 4 |
| Aug 19, 2026 | Christopher E MeadVice President | Sold | 3,500 | $257.03 | $0.9M | Form 4 |
| Jun 2, 2026 | Richard C CaryController, CAO | Sold | 3,000 | $206.00 | $0.6M | Form 4 |
| Mar 6, 2026 | Scott R HudsonVice President | Sold | 3,800 | $227.57 | $0.9M | Form 4 |
| Mar 5, 2026 | Christopher E MeadVice President | Sold | 4,000 | $227.12 | $0.9M | Form 4 |
| Mar 2, 2026 | Gallagher J Patrick JrCEO, Director | Sold | 27,450 | $230.31 | $6.3M | Form 4 |
| Dec 23, 2025 | Christopher E MeadVice President | Sold | 4,000 | $258.11 | $1.0M | Form 4 |
| Dec 22, 2025 | Douglas K HowellVP & Chief Financial Officer | Sold | 5,000 | $258.05 | $1.3M | Form 4 |
| Dec 19, 2025 | Walter D. BayGeneral Counsel | Sold | 15,850 | $255.00 | $4.0M | Form 4 |
| Nov 21, 2025 | Christopher E MeadVice President | Sold | 1,250 | $250.74 | $0.3M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 8 | 6 / 8 | 3 / 8 |
| Accruals ratio | β2.4% | β1.9% | β0.7% |
| Altman Z'' | 0.86 | 2.49 | 1.20 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Arthur J. Gallagher AJG | $68.8B | 20.7% | β | 12.8% | 9.9% | 44.5x | 3 | |
| Aon AON | $64.9B | 9.5% | 25.3% | 18.7% | 15.6% | 16.7x | 4 | Compare β |
| Willis Towers Watson WTW | $30.6B | β2.2% | 23.0% | 15.9% | 12.8% | 20.1x | 7 | Compare β |
| Marsh McLennan MRSH | $94.6B | 10.3% | 23.1% | 18.5% | 15.0% | 23.6x | 5 | Compare β |
| Brown & Brown BRO | $24.4B | 22.8% | β | 23.4% | 9.1% | 23.0x | 4 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.6B | $6.2B | $6.9B | $7.2B | $7.0B | $8.2B | $8.6B | $10.1B | $11.6B | $13.9B |
| Gross profit | $4.2B | $4.5B | $5.1B | $5.8B | $6.1B | $7.0B | $8.5B | β | β | β |
| Interest expense | $110M | $124M | $138M | $180M | $196M | $226M | $257M | $297M | $381M | $639M |
| Pretax income | $334M | $360M | $479M | $626M | $871M | $975M | $1.3B | $1.2B | $1.9B | $1.9B |
| Income tax | β$96.7M | β$157M | β$197M | β$89.7M | $12.8M | $20.1M | $211M | $219M | $404M | $368M |
| Net income | $397M | $481M | $634M | $669M | $819M | $907M | $1.1B | $970M | $1.5B | $1.5B |
| Diluted EPS | $2.22 | $2.64 | $3.40 | $3.52 | $4.20 | $4.37 | $5.19 | $4.42 | $6.50 | $5.74 |
| Diluted shares | 0.18B | 0.18B | 0.18B | 0.19B | 0.19B | 0.20B | 0.21B | 0.21B | 0.22B | 0.26B |
| Cash flow | ||||||||||
| Cash from operations | $650M | $854M | $765M | $1.2B | $1.8B | $1.4B | $1.4B | $2.0B | $2.6B | $1.9B |
| Capital expenditure | $218M | $129M | $124M | $139M | $99.3M | $129M | $183M | $194M | $142M | $145M |
| Free cash flow | $432M | $725M | $641M | $1.1B | $1.7B | $1.3B | $1.2B | $1.8B | $2.4B | $1.8B |
| Depreciation and amortization | $351M | $386M | $419M | $474M | $562M | $566M | $600M | $697M | $843M | $1.1B |
| Stock-based compensation | $14.7M | $17.3M | $13.7M | $14.0M | $13.6M | $13.4M | $24.4M | $31.0M | $42.0M | $49.0M |
| Acquisitions | $327M | $372M | $792M | $1.3B | $398M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $101M | $17.7M | $11.3M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $272M | $283M | $302M | $321M | $347M | $392M | $430M | $474M | $525M | $667M |
| Dividends and buybacks | $373M | $300M | $313M | $321M | $347M | $392M | $430M | $474M | $525M | $667M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $546M | $681M | $607M | $605M | $665M | $403M | $738M | $971M | $15.0B | $1.4B |
| Total debt | $605M | $310M | $385M | $639M | $94.6M | $268M | $327M | $694M | $223M | $13.5B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $4.4B | $7.3B | $8.1B | $9.1B | $11.1B | $17.7B | $22.3B | $32.1B | $44.1B | $34.4B |
| Current liabilities | $4.6B | $6.7B | $7.7B | $8.9B | $10.1B | $16.7B | $21.3B | $31.1B | $29.3B | $32.5B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $378M | $412M | $437M | $467M | $451M | $501M | $576M | $726M | $650M | $789M |
| Total assets | $13.5B | $14.9B | $16.3B | $19.6B | $22.3B | $33.2B | $38.4B | $51.6B | $64.3B | $70.7B |
| Total liabilities | $7.8B | $10.6B | $11.8B | $14.4B | $16.1B | $24.8B | $29.2B | $40.8B | $44.1B | $47.3B |
| Shareholders' equity | $3.6B | $4.2B | $4.5B | $5.2B | $6.2B | $8.5B | $9.1B | $10.8B | $20.2B | $23.3B |
| Margins | ||||||||||
| Gross margin | 74.8% | 73.4% | 73.8% | 81.2% | 87.4% | 85.7% | 99.7% | β | β | β |
| EBITDA margin | 14.2% | 14.1% | 15.0% | 17.8% | 23.3% | 21.5% | 25.5% | 21.6% | 26.8% | 26.1% |
| Net margin | 7.1% | 7.8% | 9.1% | 9.3% | 11.7% | 11.1% | 13.0% | 9.6% | 12.7% | 10.7% |
| FCF margin | 7.7% | 11.8% | 9.2% | 14.6% | 24.4% | 15.4% | 14.1% | 18.3% | 21.1% | 12.8% |
| Returns | ||||||||||
| Return on capital | 12.1% | 12.5% | 14.9% | 16.8% | 19.3% | 16.7% | 15.5% | 12.5% | 22.2% | 9.9% |
| Return on capital employed | 5.7% | 5.7% | 7.4% | 8.3% | 9.3% | 8.4% | 9.5% | 7.9% | 8.1% | 6.9% |
| Return on equity | 11.0% | 12.3% | 14.5% | 13.9% | 14.4% | 12.3% | 12.6% | 9.7% | 9.5% | 6.9% |
| Return on assets | 3.3% | 3.4% | 4.1% | 3.7% | 3.9% | 3.3% | 3.1% | 2.2% | 2.5% | 2.2% |
| Growth | ||||||||||
| Revenue growth | 3.8% | 10.1% | 12.6% | 3.8% | β2.7% | 17.2% | 4.2% | 17.8% | 14.7% | 20.7% |
| Net income growth | 11.2% | 21.3% | 31.6% | 5.6% | 22.4% | 10.8% | 22.9% | β12.9% | 50.8% | 2.1% |
| EPS growth | 7.8% | 18.9% | 28.8% | 3.5% | 19.3% | 4.1% | 18.8% | β14.8% | 47.1% | β11.7% |
| FCF growth | β26.5% | 67.9% | β11.6% | 64.2% | 62.3% | β26.0% | β4.5% | 52.2% | 32.8% | β26.9% |
| Share count change | 3.1% | 1.4% | 1.4% | 1.8% | 2.7% | 6.1% | 3.8% | 2.2% | 2.6% | 16.2% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.1x | β0.4x | β0.2x | 0.0x | β0.4x | β0.1x | β0.2x | β0.1x | β4.8x | 3.3x |
| Debt / equity | 0.2x | 0.1x | 0.1x | 0.1x | 0.0x | 0.0x | 0.0x | 0.1x | 0.0x | 0.6x |
| Interest coverage | 4.0x | 3.9x | 4.5x | 4.5x | 5.4x | 5.3x | 6.2x | 5.0x | 5.9x | 3.9x |
| Current ratio | 1.0x | 1.1x | 1.1x | 1.0x | 1.1x | 1.1x | 1.0x | 1.0x | 1.5x | 1.1x |
| Quick ratio | 1.0x | 1.1x | 1.1x | 1.0x | 1.1x | 1.1x | 1.0x | 1.0x | 1.5x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 3.9% | 2.1% | 1.8% | 1.9% | 1.4% | 1.6% | 2.1% | 1.9% | 1.2% | 1.0% |
| Stock comp / revenue | 0.3% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | 0.3% | 0.4% | 0.4% |
| Payouts / FCF | 86.4% | 41.4% | 48.9% | 30.5% | 20.3% | 31.0% | 35.6% | 25.8% | 21.5% | 37.4% |
| Quality scores | ||||||||||
| Piotroski F-score | 4.0 | 5.0 | 6.0 | 4.0 | 7.0 | 4.0 | 5.0 | 4.0 | 6.0 | 3.0 |
| Altman Z'' | 0.9 | 1.2 | 1.1 | 1.0 | 1.4 | 1.1 | 1.1 | 0.9 | 2.5 | 1.2 |
| Accruals ratio | β2.1% | β2.6% | β0.8% | β2.9% | β4.7% | β1.8% | β0.8% | β2.4% | β1.9% | β0.7% |
Source: SEC EDGAR XBRL filings (CIK 0000354190). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.